Immune Checkpoint Inhibition-Does It Cause Rheumatic Diseases? Mechanisms of Cancer-Associated Loss of Tolerance and Pathogenesis of Autoimmunity
- PMID: 32631606
- DOI: 10.1016/j.rdc.2020.04.003
Immune Checkpoint Inhibition-Does It Cause Rheumatic Diseases? Mechanisms of Cancer-Associated Loss of Tolerance and Pathogenesis of Autoimmunity
Abstract
Mechanisms of immune checkpoints and their role in autoimmunity are discussed in the context of immune checkpoint inhibitor (ICI) therapy for cancer. The updated clinical spectrum of immune-related adverse events (irAEs), with an in-depth discussion of rheumatic irAEs, is presented. The relationship between ICI-induced loss of self-tolerance in cancer and the implications for understanding of irAEs, rheumatic irAEs in particular, is overviewed.
Keywords: Autoimmunity; Immune checkpoint inhibitors; Immune-related adverse events; Rheumatic diseases; Tolerance.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure Dr. Thanarajasingam is supported by the “Catalyst” award for Advancing in Academics Program, funded by the Department of Medicine, Mayo Clinic, Rochester, MN.
Similar articles
-
Rheumatic Complications of Immune Checkpoint Inhibitors.Med Clin North Am. 2021 Mar;105(2):227-245. doi: 10.1016/j.mcna.2020.09.009. Med Clin North Am. 2021. PMID: 33589099 Review.
-
Spectrum and impact of checkpoint inhibitor-induced irAEs.Nat Rev Rheumatol. 2021 Feb;17(2):69-70. doi: 10.1038/s41584-020-00546-2. Nat Rev Rheumatol. 2021. PMID: 33235330 No abstract available.
-
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events.Rheum Dis Clin North Am. 2024 May;50(2):181-199. doi: 10.1016/j.rdc.2024.01.003. Epub 2024 Feb 22. Rheum Dis Clin North Am. 2024. PMID: 38670720 Review.
-
Understanding adverse events of immunotherapy: A mechanistic perspective.J Exp Med. 2021 Jan 4;218(1):e20192179. doi: 10.1084/jem.20192179. J Exp Med. 2021. PMID: 33601411 Free PMC article. Review.
-
Management of immune checkpoint inhibitor-related rheumatic adverse events.Thorac Cancer. 2020 Jan;11(1):198-202. doi: 10.1111/1759-7714.13249. Epub 2019 Nov 24. Thorac Cancer. 2020. PMID: 31762209 Free PMC article.
Cited by
-
Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis following the administration of nivolumab: A case report.World J Clin Cases. 2022 Jul 16;10(20):7124-7129. doi: 10.12998/wjcc.v10.i20.7124. World J Clin Cases. 2022. PMID: 36051149 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical